Correlation Between Biotechnology Fund and Global Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Global Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Global Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Global Technology Portfolio, you can compare the effects of market volatilities on Biotechnology Fund and Global Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Global Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Global Technology.

Diversification Opportunities for Biotechnology Fund and Global Technology

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between BIOTECHNOLOGY and Global is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Global Technology Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Global Technology and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Global Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Global Technology has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Global Technology go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Global Technology

Assuming the 90 days horizon Biotechnology Fund is expected to generate 3.28 times less return on investment than Global Technology. But when comparing it to its historical volatility, Biotechnology Fund Class is 1.19 times less risky than Global Technology. It trades about 0.04 of its potential returns per unit of risk. Global Technology Portfolio is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1,372  in Global Technology Portfolio on August 31, 2024 and sell it today you would earn a total of  750.00  from holding Global Technology Portfolio or generate 54.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Fund Class  vs.  Global Technology Portfolio

 Performance 
       Timeline  
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Global Technology 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Global Technology Portfolio are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Global Technology may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Biotechnology Fund and Global Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Fund and Global Technology

The main advantage of trading using opposite Biotechnology Fund and Global Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Global Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Global Technology will offset losses from the drop in Global Technology's long position.
The idea behind Biotechnology Fund Class and Global Technology Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance